dsm-firmenich's Strategic Share Repurchase Program Update
dsm-firmenich, a leading innovator in nutrition, health, and beauty, has recently embarked on a notable share repurchase program aimed at enhancing shareholder value and addressing capital structure. Announced initially on February 13, 2025, the company revealed its intention to repurchase ordinary shares totaling an impressive €1 billion. This program is designed to cover commitments under the group's share-based compensation plans while also aiming to lower the overall issued capital of the company.
Progress of the Share Repurchase Program
Starting from April 1, 2025, dsm-firmenich initiated a significant share buyback program with a total budget of €580 million. This well-structured initiative included €80 million earmarked for fulfilling commitments related to the Group’s employee share plans and the remaining €500 million dedicated to reducing the company’s issued capital. The strategic planning showcases dsm-firmenich's commitment to boosting shareholder confidence and implementing changes that favor long-term growth.
Recent Share Buyback Activities
In compliance with market regulations, dsm-firmenich disclosed that from April 28, 2025, until May 2, 2025, the company repurchased a total of 139,914 shares at an average price of €94.61 each, amounting to approximately €13.2 million. To date, the cumulative shares repurchased under this program stand at 785,129, with an average purchase price of €90.17, culminating in a total investment of about €70.8 million.
Future Outlook and Additional Plans
The initial phase of the €580 million share repurchase is on track to be completed within six months of its commencement. dsm-firmenich has articulated plans to launch an additional €500 million share repurchase program following the successful disposal of its stake in the Feed Enzymes Alliance. This forward-looking approach signals the company’s commitment to returning value to its shareholders while maintaining strategic flexibility.
Importance of Share Repurchase Programs
Share repurchase programs are critical for companies like dsm-firmenich as they not only provide capital back to shareholders but also help in reducing the number of outstanding shares, potentially increasing earnings per share (EPS). By strategically managing its capital structure, dsm-firmenich aims to create a balanced investment strategy that enhances market performance and appeals to current and prospective investors.
Company Overview
Founded with innovation at its core, dsm-firmenich serves a vast global community by manufacturing and blending crucial nutrients, flavors, and fragrances. The company prides itself on using natural and renewable resources, combined with scientific expertise to deliver sustainable solutions. Operating across nearly 60 countries and generating revenues exceeding €12 billion, dsm-firmenich maintains a workforce of approximately 30,000 employees, all dedicated to propelling progress and enhancing the quality of life worldwide.
Contact Information
For investor relations inquiries or more information about dsm-firmenich, please reach out via the following contacts:
Investor Relations:
Email: investors@dsm-firmenich.com
Media Inquiries:
Email: media@dsm-firmenich.com
Frequently Asked Questions
What is dsm-firmenich's share repurchase program about?
The share repurchase program involves buying back ordinary shares to enhance shareholder value and reduce the number of outstanding shares.
How much does dsm-firmenich plan to repurchase?
Initially, the company plans to repurchase shares worth €1 billion, with the first phase involving €580 million.
What is the current status of the share repurchase program?
As of now, dsm-firmenich has repurchased 785,129 shares at an average price of approximately €90.17.
What are the future plans regarding this program?
Upon completing the initial program, an additional €500 million repurchase program is planned following the sale of a certain stake in an alliance.
How does a share repurchase program affect shareholders?
Such programs can increase earnings per share (EPS) by reducing the number of shares available in the market, thereby enhancing shareholder value.
